Number of the records: 1  

Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia

  1. TitleAnti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia
    Author Pucciarelli D.
    Co-authors Lengger N.

    Takáčová Martina 1981 SAVVIR - Virologický ústav SAV

    Csáderová Lucia 1971 SAVVIR - Virologický ústav SAV    ORCID

    Bartošová Mária 1974 SAVVIR - Virologický ústav SAV    ORCID

    Breiteneder H.

    Pastoreková Silvia 1961 SAVVIR - Virologický ústav SAV    ORCID

    Hafner C.

    Source document International Journal of Oncology. Vol. 47, no. 1 (2015), p. 81-90
    Languageeng - English
    CountryGR - Greece
    Document kindrozpis článkov z periodík (rbx)
    CitationsROLIH, Valeria - BARUTELLO, Giuseppina - IUSSICH, Selina - DE MARIA, Raffaella - QUAGLINO, Elena - BURACCO, Paolo - CAVALLO, Federica - RICCARDO, Federica. CSPG4: a prototype oncoantigen for translational immunotherapy studies. In JOURNAL OF TRANSLATIONAL MEDICINE. ISSN 1479-5876, 2017, vol. 15, no., pp.
    AMPOFO, Emmanuel - SCHMITT, Beate M. - MENGER, Michael D. - LASCHKE, Matthias W. The regulatory mechanisms of NG2/CSPG4 expression. In CELLULAR & MOLECULAR BIOLOGY LETTERS. ISSN 1425-8153, 2017, vol. 22, no., pp. 1-9.
    PUECH, Clementine - CHATARD, Morgane - FELDER-FLESCH, Delphine - PREVOT, Nathalie - PEREK, Nathalie. Umbelliferone Decreases Intracellular pH and Sensitizes Melanoma Cell Line A375 to Dacarbazin. Comparison with Acetazolamide. In CURRENT MOLECULAR PHARMACOLOGY. ISSN 1874-4672, 2018, vol. 11, no. 2, pp. 133-139.
    PRIETO, C. - LOPEZ-MILLAN, B. - ROCA-HO, H. - STAM, R. W. - ROMERO-MOYA, D. - RODRIGUEZ-BAENA, F. J. - SANJUAN-PLA, A. - AYLLON, V. - RAMIREZ, M. - BARDINI, M. - DE LORENZO, P. - VALSECCHI, M. G. - STANULLA, M. - IGLESIAS, M. - BALLERINI, P. - CARCABOSO, A. M. - MORA, J. - LOCATELLI, F. - BERTAINA, A. - PADILLA, L. - CARLOS RODRIGUEZ-MANZANEQUE, J. - BUEN, C. - MENENDEZ, P. NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL. In LEUKEMIA. ISSN 0887-6924, 2018, vol. 32, no. 3, pp. 633-644.
    ILIEVA, Kristina M. - CHEUNG, Anthony - MELE, Silvia - CHIARUTTINI, Giulia - CRESCIOLI, Silvia - GRIFFIN, Merope - NAKAMURA, Mano - SPICER, James F. - TSOKA, Sophia - LACY, Katie E. - TUTT, Andrew N. J. - KARAGIANNIS, Sophia N. Chondroitin Sulfate Proteoglycan 4 and its Potential As an Antibody immunotherapy Target across Different Tumor Types. In FRONTIERS IN IMMUNOLOGY. ISSN 1664-3224, 2018, vol. 8, no., pp.
    WEI, J.F. - HU, M.L. - HUANG, K.T. - LIN, S.D. - DU, H.L. Roles of Proteoglycans and Glycosaminoglycans in Cancer Development and Progression. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. SEP 2020, vol. 21, no. 17.
    MAGGS, L. - FERRONE, S. Improving the Clinical Significance of Preclinical Immunotherapy Studies through Incorporating Tumor Microenvironment-like Conditions. In CLINICAL CANCER RESEARCH. ISSN 1078-0432, SEP 1 2020, vol. 26, no. 17, p. 4448-4453.
    ESPINOZA-SANCHEZ, N.A. - GOTTE, M. Role of cell surface proteoglycans in cancer immunotherapy. In SEMINARS IN CANCER BIOLOGY. ISSN 1044-579X, MAY 2020, vol. 62, p. 48-67.
    FURFARO, A.L. - LOI, G. - IVALDO, C. - PASSALACQUA, M. - PIETRA, G. - MANN, G.E. - NITTI, M. HO-1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAFSUPV600E/SUP Mutated Melanoma Cells Adapted to Physiological Normoxia or Hypoxia. In ANTIOXIDANTS. JUN 2022, vol. 11, no. 6. Dostupné na: https://doi.org/10.3390/antiox11061171.
    CategoryADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2015
    Registered inWOS
    Registered inSCOPUS
    Registered inCCC
    DOI 10.3892/ijo.2015.3010
    article

    article

    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    201520143.025Q21.262Q2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.